Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2023
Archives
Using of opioids for chronic pain: Controversies, guidelines, research needs
First in a series of five articles, Norm Buckley and Jason Busse explore the trials and tribulations associated with using opioids for chronic pain, particularly in Canada.
How can the health sector support Canada’s net-zero ambition?
Fiona A. Miller, Professor & Director at the Centre for Sustainable Health Systems, University of Toronto in Canada, explores how the health sector supports Canada’s net-zero ambition.
Acute care hospital reform in Japan: Outcomes in quality and market competition
This paper describes why the fee system for acute care hospital reform in Japan is beginning to show results.
Revolutionary pain relief cream and two-minute exercise to cure and prevent lower back pain
Dr Helene Bertrand has specialised in pain treatment after suffering from ongoing lower back pain for 37 years. Here in conversation with Open Access Government, Helene explores her lower back pain journey and the ways she has found to heal herself.
EAT2beNICE Project: The correlation between diet and mental health
Jeanette C. Mostert & Alejandro Arias Vasquez from the Departments of Genetics and Psychiatry, Radboud University Medical Center Nijmegen, The Netherlands, reveal that diet and mental health are linked, as they reflect on the lessons learned from the Eat2beNICE project.
The global regulatory landscape for psychedelic drugs
Jessica Riggleman, Owner of Raeco, LLC, examines the global regulatory landscape for psychedelic drugs, with a particular focus on Schedule I classification.
HIV therapeutic targets: Basic virology to the discovery of antiretroviral drugs
Do we need new antiretroviral drugs to treat HIV infection, and if so, what are the promising targets? Dr Eric O. Freed, Director of the HIV Dynamics and Replication Program at the National Cancer Institute in Frederick, Maryland, discusses these questions.
Personalized diet intervention in Thai ageing populations
Professor Apichart Vanavichit a Rice Genomic Breeding Expert at the Rice Science Center looks at diet intervention and therapy for the ageing population of Thailand to prevent disease.
Peroxisomes, lipids, and neurodegeneration
Prof. Michael Schrader at the University of Exeter looks to understand the role of peroxisomes in human health and disease.
Can we produce new medicines from microalgae?
Inflammatory bowel disease (IBD) is a chronic inflammation in the digestive tract. Currently no effective treatment exists, something that the researchers of the EU-funded Algae4IBD project want to change with the help of microalgae.
Fostering nonhuman primate (NHP) brain research without animal sacrifice
The MacBrain Resource Center (MBRC) at Yale University School of Medicine is positioning itself at the forefront of innovative ways to provide cost-effective means for scientists to conduct de novo nonhuman primate brain research with extant materials.
Paediatric autism communication therapy improved long-term child outcomes
Paediatric Autism Communication Therapy is currently the only scientifically evidenced early social communication intervention to demonstrate long-term improved child social communication outcomes into middle...
Beyond amyloid: What’s next for Alzheimers disease therapeutics?
Bradlee Heckmann, PhD, from USF Health Neuroscience Institute, Byrd Alzheimer’s Center & Asha Therapeutics, in this discussion goes beyond amyloid, asking what’s next for Alzheimer’s Disease therapeutics.
Precision medicine: Sensorineural hearing loss treatment
Aarno Dietz, Professor of Otorhinolaryngology at Kuopio University Hospital, turns the spotlight on hospital precision medicine, focusing on the treatment of sensorineural hearing loss.
Visualizing the anti-inflammatory cannabinoid Type-2 receptor
Medicinal chemists describe how small molecule probes allow for the detection of CB2R, and thereby enable the discovery of novel anti-inflammatory treatments.
Solutions for healthy ageing: how technology can make a difference
Professor Alex Mihailidis, Scientific Director and CEO of AGE-WELL Network of Centres of Excellence, looks to improve wellbeing and healthy ageing in older people through innovative technology.
Ensuring healthier pets through improved nutrient precision in pet foods
Improved nutrient precision in pet foods is critical to pets, people & planet; Dennis E. Jewell, PhD from Kansas State University & Matthew I. Jackson, PhD from Hill’s Pet Nutrition, explain.
RR-TB treatments, testing bedaquiline and injectable kanamycin
Here, Professor Andre Nunn from Medical Research Council Clinical Trials Unit at UCL, explores tuberculosis with a focus on RR-TB treatments (rifampicin-resistant) and their drug combinations.
Psychedelic therapies are returning to psychiatry
Professor Erika Dyck, Canada Research Chair in History of Health & Social Justice at the University of Saskatchewan, looks to psychedelic therapies outside the pharmaceutical industry to aid mental illness.
PopART: Universal testing and treatment to stop HIV spread
Here, Professor of Epidemiology & International Health Richard Hayes explores and details the PopART study and other trials of Universal Testing and Treatment, a promising strategy to reduce HIV spread.
